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The production of safe and effective pharmaceutical products with standard quality requires permanent monitoring, 
control and quality assurance of everything that is involved in the production process. To meet the stringent 
requirements of the pharmacopoeia regulations, it is necessary to carry out quality control tests of incoming raw 
materials continuously, including quality control of active substances, excipients and packaging material. A huge 
number of manuals, protocols, standard operating procedures, pharmacopoeia regulations and guidelines which 
provide additional information for monitoring and ensuring the quality of raw materials in the pharmaceutical 
industry are available.  
The aim of this study was to compare the requirements included in the monographs of the European, American and 
Indian Pharmacopoeia, as well as, in the Handbook of Pharmaceutical Excipients and to estimate them as in process 
control parameters for evaluation of the quality of raw materials in production of Paracetamol tablets á 500 mg. The 
monographs for paracetamol, sodium starch glycolate, stearic acid, pregelatinized starch and povidon were 
compared. The comparison of the pharmacopoeia regulations for packing material dedicated for oral use included in 
the European, United States and Indian Pharmacopoeias was also done.  
From the comparisons made, it can be noted that the requirements included in the monographs of these three 
pharmacopoeias are largely similar, so we can conclude that there is compliance within the pharmacopoeia 
requirements. The only significant differences were observed in the part concerning the packing material. European 
Pharmacopoeia contains monograph specific for each type of packaging material while applications relating to 
packaging materials in the US and Indian Pharmacopoeia are not placed in separate monographs. 
In industrial conditions, the quality control specifications may also include other requirements and tests that are not 
included in the monographs of the pharmacopoeia, as is necessary for defining the quality of incoming raw 
materials. Fulfilling all the requirements included in the specifications for quality of all incoming raw materials and 
respecting the standards of good manufacturing practice provides assurance that we will achieve the required 
quality, efficiency and reliability of the finished pharmaceutical product. 
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